News

News from GMP Market and about Valicare

News from around the world

Our international press review contains a selection of news and recent articles on advanced therapy medicinal products (ATMPs), chimeric antigen receptor T-cell therapy (CAR), tumor infiltrating lymphocytes (TILs) and bioengineered tissue products (TEPs).

Early Trial Data Show Crispr Cancer Therapy Response

13.05.2022 | Science & Enterprise

13 May 2022. Initial results from a clinical trial show non-Hodgkin lymphoma patients receiving low doses of gene-edited T-cells achieve a ...

CRISPR Therapeutics’ CAR-T for Lymphoma Shows Early Promise

12.05.2022 | BioSpace

Biotech Bay

05.12.22 -- Your New EU IDMP Implementation Strategy

12.05.2022 | Pharmaceutical Online

On Cell & Gene: The Podcast, Amit Kumar, Ph.D., CEO at Anixa Biosciences, details the progress on their Phase 1 trial for ovarian cancer ...

Repairing tendons with silk proteins

12.05.2022 | Orthopaedic Product News

Sudden or repetitive motion, experienced by athletes and factory workers, for example, increases the risk of tears or ruptures in the ...

A guide to the organ-on-a-chip

12.05.2022 | Nature

Organs-on-chips (OoCs) are systems containing engineered or natural miniature tissues grown inside microfluidic chips. To better mimic ...

On the Prognostic Power of Tumor-Infiltrating Lymphocytes – A Critical Commentary

12.05.2022 | Frontiers

Introduction Tumor-infiltrating lymphocytes can affect cancer progression. Tumor-infiltrating lymphocytes may generally be classified as ...

Recent Advances in Chitosan and its Derivatives in Cancer Treatment

11.05.2022 | Frontiers

1 Introduction Cancer has been becoming a life-threatening disease and a major public health problem all over the world, which is one of ...

Scaling Up Cell Therapies Capacity

11.05.2022 | BioPharm International

Outsourcing partners are ready to fill the market need for greater cell therapies capacities.

Shining a Spotlight on Nucleic Acid-Based Therapeutics

11.05.2022 | BioPharm International

Further development of nucleic acid-based therapeutics has been accelerated by the recent success of mRNA vaccines.

BioNTech Forges Ahead in Oncology, Infectious Disease

10.05.2022 | PharmaLive

BioNTech Forges Ahead in Oncology, Infectious Disease

Bone Therapeutics is Breaking New Ground in Bone Remodeling

09.05.2022 | BioSpace

Biotech Bay

Neues aus dem Tissue Engineering: Wie der 3D-Druck hilft

09.05.2022 | medizin & technik

Gestärkte Immunzellen für den Kampf gegen Krebs

07.05.2022 | Krebs-Nachrichten

Gut microbiome as a tool in regenerative medicine; Novel approach driven by GN Corp Japan with potentials in neurological illnesses

07.05.2022 | American Press

Regenerative medicine uses tools that include cells (stem cells, progenitors, mature adult cells), cell-derived factors (cytokines), and ...

Bispecific Antibodies With Multiple Targets Moving Forward in Multiple Myeloma

06.05.2022 | The Asco Post

Poor outcomes are observed in patients with myeloma who are refractory to multiple classes of therapies, with the average patient ...

We are there for you

Contact us if you have any questions. We will gladly answer and advise you.

Contact